October 7, 2021
November 12, 2019
April 28, 2020
January 20, 2021
March 26, 2012
Bill Would Expedite FDA Approval and Increase Clinical Trial Flexibility of Drugs and Treatments That Show Dramatic Early Responses – Washington, DC – Senators Michael Bennet (D-CO), Orrin Hatch (R-UT) and Richard Burr (R-NC) today introduced a bipartisan bill to help bring breakthrough drugs and treatments to patients who need them more quickly. The Advancing…
Learn MoreMarch 23, 2012
The SSO Recognized Paulsen for Her Leadership of the Entertainment Industry Foundation, Including Her Efforts in the Creation of the “Stand Up To Cancer” Initiative – Los Angeles, CA – March 23, 2012 – The Society of Surgical Oncology (SSO) and its James Ewing Foundation recognized the efforts of Stand Up to Cancer’s co-founder Lisa…
Learn MoreMarch 8, 2012
Thursday, March 8, 2012, the House Energy and Commerce Committee Subcommittee on Health held a hearing titled, “FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain.” The three panel hearing convened members of government, academia, and industry to address pressing issues surrounding the reauthorization…
Learn MoreFebruary 9, 2012
On Thursday, February 9, 2012, the House Energy and Commerce Subcommittee on Health held the second in a series of hearings regarding the reauthorization of the Prescription Drug User Fee Act, the Medical Device User Fee Act, and the creation of the Generic User Fee and Biosimilar User Fee Acts. The two-panel hearing also covered…
Learn MoreFebruary 2, 2012
On Wednesday, February 1, 2012, the House Energy and Commerce Subcommittee on Health held a hearing to discuss the upcoming reauthorization of the Prescription Drug User Fee Act, among other things. FDA Commissioner Dr. Margaret Hamburg served as the witness to the first panel. A second panel consisted of Geno Germano, president and general manager…
Learn MoreJanuary 13, 2012
The U.S. Food and Drug Administration has completed its recommendations for three user fee programs that will help speed safe and effective drugs and lower-cost generic drug and biosimilar biological products to patients, FDA Commissioner Margaret A. Hamburg, M.D. said today. The recommendations were transmitted to Congress today by Health and Human Services Secretary Kathleen Sebelius.…
Learn MoreOctober 31, 2011
WASHINGTON, D.C., Oct 28, 2011 (BUSINESS WIRE) – Susan G. Komen for the Cure(R) tonight paid tribute to global leaders in the fight against breast cancer, including the late Betty Ford, at a star-studded event at the John F. Kennedy Center for the Performing Arts for the second annual “Honoring the Promise” gala. Breast cancer…
Learn MoreOctober 19, 2011
Friends of Cancer Research Video Narrated by Oscar-Winning Actor and Cancer Survivor Michael Douglas
Learn More